Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8.
Article
CAS
PubMed
Google Scholar
Park EH, Min SY, Kim Z, Yoon CS, Jung KW, Nam SJ, et al. Basic facts of breast cancer in Korea in 2014: the 10-year overall survival progress. J Breast Cancer. 2017;20(1):1–11.
Article
PubMed
PubMed Central
Google Scholar
Bardia A, Hurvitz S. Targeted therapy for premenopausal women with HR+, HER2- advanced breast cancer: focus on special considerations and latest advances. Clin Cancer Research. 2018;24:2506–18.
Article
Google Scholar
Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. 2011;17(18):6012–20.
Article
CAS
PubMed
Google Scholar
Rayhanabad JA, Difronzo LA, Haigh PI, Romero L. Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm. Am Surg. 2008;74(10):887–90.
PubMed
Google Scholar
Sapino A, Roepman P, Linn SC, Snel MH, Delahaye LJ, van den Akker J, et al. MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue. J Mol Diagn. 2014;16(2):190–7.
Article
CAS
PubMed
Google Scholar
Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378(9805):1812–23.
Article
CAS
PubMed
Google Scholar
Kittaneh M, Montero AJ, Gluck S. Molecular profiling for breast cancer: a comprehensive review. Biomark Cancer. 2013;5:61–70.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412–24.
Article
PubMed
PubMed Central
Google Scholar
Wee Y, Liu Y, Lu J, Li X, Zhao M. Identification of novel prognosis-related genes associated with cancer using integrative network analysis. Sci Rep. 2018;8(1):3233.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jonsdottir K, Assmus J, Slewa A, Gudlaugsson E, Skaland I, Baak JP, et al. Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer. PLoS One. 2014;9(3):e90642.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zins K, Heller G, Mayerhofer M, Schreiber M, Abraham D. Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes. Oncotarget. 2018;9(33):23126–48.
Article
PubMed
PubMed Central
Google Scholar
Liu MC, Pitcher BN, Mardis ER, Davies SR, Friedman PN, Snider JE, et al. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance). NPJ Breast Cancer. 2016;2.
Kim JKB, Bae S, Han S, Jun A, Han J, Cho M, Choi Y, Lee J, Moon Y. An analytical validation of the GenesWellTM BCT multigene prognostic test in patients with early breast cancer. Korean J Clin Lab Sci. 2017;49:79–87.
Article
Google Scholar
Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, et al. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer. 2003;97(12):2960–71.
Article
CAS
PubMed
Google Scholar
Zanetti-Dallenbach R, Vuaroqueaux V, Wight E, Labuhn M, Singer G, Urban P, et al. Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples. Breast Cancer Res. 2006;8(4):R51.
Article
PubMed
PubMed Central
CAS
Google Scholar
Muller BM, Brase JC, Haufe F, Weber KE, Budzies J, Petry C, et al. Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections. J Clin Pathol. 2012;65(7):660–2.
Article
PubMed
Google Scholar
Drubin D, Smith JS, Liu W, Zhao W, Chase GA, Clawson GA. Comparison of cryopreservation and standard needle biopsy for gene expression profiling of human breast cancer specimens. Breast Cancer Res Treat. 2005;90(1):93–6.
Article
CAS
PubMed
Google Scholar
You K, Park S, Ryu JM, Kim I, Lee SK, Yu J, et al. Comparison of core needle biopsy and surgical specimens in determining intrinsic biological subtypes of breast cancer with immunohistochemistry. J Breast Cancer. 2017;20(3):297–303.
Article
PubMed
PubMed Central
Google Scholar
Chen X, Yuan Y, Gu Z, Shen K. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;134(3):957–67.
Article
CAS
PubMed
Google Scholar
Chen X, Sun L, Mao Y, Zhu S, Wu J, Huang O, et al. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer. 2013;13:390.
Article
PubMed
PubMed Central
Google Scholar
Gong G, Kwon MJ, Han J, Lee HJ, Lee SK, Lee JE, et al. A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer. Sci Rep. 2017;7:45554.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79.
Article
PubMed
PubMed Central
Google Scholar
Narod SA, Iqbal J, Miller AB. Why have breast cancer mortality rates declined? J Cancer Policy. 2015;5:8–17.
Article
Google Scholar
Sinn P, Aulmann S, Wirtz R, Schott S, Marme F, Varga Z, et al. Multigene assays for classification, prognosis, and prediction in breast cancer: a critical review on the background and clinical utility. Geburtshilfe Frauenheilkd. 2013;73(9):932–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5(10):2929–43.
CAS
PubMed
PubMed Central
Google Scholar
Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, Lee Y, et al. Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS One. 2009;4(7):e6162.
Article
PubMed
PubMed Central
CAS
Google Scholar
Varga Z, Sinn P, Fritzsche F, von Hochstetter A, Noske A, Schraml P, et al. Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer. PLoS One. 2013;8(3):e58483.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobagyi GN. Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist. 2008;13(5):477–93.
Article
PubMed
Google Scholar
Prat A, Parker JS, Fan C, Cheang MC, Miller LD, Bergh J, et al. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Ann Oncol. 2012;23(11):2866–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Na KY, Kim KS, Lee JE, Kim HJ, Yang JH, Ahn SH, et al. The 70-gene prognostic signature for korean breast cancer patients. J Breast Cancer. 2011;14(1):33–8.
Article
PubMed
PubMed Central
Google Scholar
Ishitobi M, Goranova TE, Komoike Y, Motomura K, Koyama H, Glas AM, et al. Clinical utility of the 70-gene MammaPrint profile in a Japanese population. Jpn J Clin Oncol. 2010;40(6):508–12.
Article
PubMed
Google Scholar
Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R. Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis. 2013;5(Suppl 1):S9–s18.
PubMed
PubMed Central
Google Scholar
Ontario HQ. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(3):1–55.
Google Scholar
Ensani F, Omranipour R, Jahanzad I, Jafari A, Nafarzadeh S, Aminishakib P. The core needle and surgical biopsy concordance to detect estrogen, progesterone, and Her-2 receptors in breast cancer: a comparative study. Iran J Pathol. 2017;12(3):202–8.
PubMed
PubMed Central
Google Scholar
Grimsby GM, Gray R, Dueck A, Carpenter S, Stucky CC, Aspey H, et al. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging? Am J Surg. 2009;198(4):500–4.
Article
PubMed
Google Scholar
Choi WJ, Cha JH, Kim HH, Shin HJ, Chae EY. The accuracy of breast MR imaging for measuring the size of a breast cancer: analysis of the histopathologic factors. Clin Breast Cancer. 2016;16(6):e145–e52.
Article
PubMed
Google Scholar